Quantbot Technologies LP Makes New $685,000 Investment in Azenta, Inc. (NASDAQ:AZTA)

Quantbot Technologies LP bought a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 13,705 shares of the company's stock, valued at approximately $685,000.

Several other institutional investors and hedge funds have also made changes to their positions in AZTA. Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the period. KBC Group NV grew its stake in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of Azenta in the 4th quarter valued at approximately $200,000. Catalyst Funds Management Pty Ltd increased its holdings in shares of Azenta by 123.0% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company's stock worth $234,000 after buying an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC purchased a new stake in shares of Azenta during the 4th quarter valued at approximately $293,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Performance

Shares of AZTA traded down $0.52 during midday trading on Tuesday, hitting $34.12. 441,653 shares of the stock were exchanged, compared to its average volume of 608,574. Azenta, Inc. has a 52-week low of $33.33 and a 52-week high of $63.58. The stock has a fifty day simple moving average of $44.35 and a 200 day simple moving average of $46.08. The firm has a market cap of $1.56 billion, a P/E ratio of -11.45 and a beta of 1.52.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC increased their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Evercore ISI boosted their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Stephens reaffirmed an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Azenta has an average rating of "Hold" and an average target price of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.